SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000062391-98-000007
Filing Date
1998-04-01
Accepted
1998-04-01 00:00:00
Documents
2
Group Members
HMR PHARMA, INC.HOECHST MARION ROUSSEL INC
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 LYNX THERAPEUTICS 13G SC 13G 13626
2 EXHIBIT 99.A TO LYNX THERAPEUTICS 13G EX-99 1240
  Complete submission text file 0000062391-98-000007.txt   17282
Mailing Address 10236 MARION PARK DRIVE P O BOX 9627 KANSAS CITY MO 64134-0627
Business Address 10236 MARION PARK DRIVE P O BOX 9627 KANSAS CITY MO 64134-0627 8169665000
HOECHST MARION ROUSSEL INC (Filed by) CIK: 0000062391 (see all company filings)

IRS No.: 440565557 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 74545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Subject) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45671 | Film No.: 98584948
SIC: 2833 Medicinal Chemicals & Botanical Products